Inventor · Arlington, MA, US

Boris Engels

16Patents
4h-index
56Co-inventors
59Inventor score

Filing activity: Dec 19, 2014 → Mar 27, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US10287354B2 Regulatable chimeric antigen receptor Chemistry; Metallurgy 21 Active
US10525083B2 Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain Chemistry; Metallurgy 9 Active
US10640569B2 Human mesothelin chimeric antigen receptors and uses thereof Chemistry; Metallurgy 8 Active
US10577417B2 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy Chemistry; Metallurgy 4 Active
US11026976B2 Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain Chemistry; Metallurgy 2 Active
US11413340B2 Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy Human Necessities 1 Active
US12383601B2 Chimeric antigen receptors and uses thereof Chemistry; Metallurgy 0 Active
US12344651B2 CD19 and CD22 chimeric antigen receptors and uses thereof Chemistry; Metallurgy 0 Active
US11981731B2 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy Chemistry; Metallurgy 0 Active
USRE49847E1 Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain General 0 Active
US11975026B2 CD19 and CD22 chimeric antigen receptors and uses thereof Chemistry; Metallurgy 0 Active
US11578130B2 Regulatable chimeric antigen receptor Chemistry; Metallurgy 0 Active
US11999794B2 Human mesothelin chimeric antigen receptors and uses thereof Chemistry; Metallurgy 0 Active
US10189908B2 Chimeric antigen receptors recognizing cancer-specific TN glycopeptide variants Chemistry; Metallurgy 0 Active
US12186278B2 Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy Human Necessities 0 Active
US11872249B2 Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.